LUCD

MKT CAP:$199M

Lucid Diagnostics Inc

Market Cap

$199M

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$0.97-$0.15 (-13.64%)

Jun 5, 2026

52W High $1.4752W Low $0.95

Company Details

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and can...

CEO

—

IPO Date

Oct 14, 2021

Website

www.luciddx.com

Key Metrics TTM

Revenue

$5M

+23.0% YoY

Net Income

-$45M

EPS (Diluted)

Free Cash Flow

-$46M

Revenue / Share

$0.05

Gross Margin

-40.0%

Operating Margin

-959.6%

Net Margin

-876.7%

FCF Margin

-904.6%

P/S

38.8x

P/E

Earnings Reports

Q1 2026

May 13, 2026

$1M+51.7%

FY 2025

Mar 25, 2026

$5M+8.3%

Q4 2025

Mar 25, 2026

$2M+25.6%

Q3 2025

Nov 12, 2025

$1M+3.3%

Q2 2025

Aug 12, 2025

$1M+19.2%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee